SpaceX has completed the largest IPO in history, with Anthropic and OpenAI queued behind it. As pure-play AI listings arrive, the decade-long investor workaround of buying Nvidia, Microsoft, and Alphabet for indirect AI exposure is losing its structural logic. Here is what the 2026 IPO wave means for capital allocation across US equity markets.

Key Highlights

• SpaceX raised $75 billion on June 12 in the largest IPO in stock market history, listing on Nasdaq under ticker SPCX at $135 per share.

• Anthropic and OpenAI have both filed confidential S-1s, targeting combined valuations of up to $1.8 trillion ahead of their 2026 public debuts.

• Investors who held Nvidia, Microsoft, and Alphabet as AI proxy trades now have a direct route to pure-play AI exposure for the first time.

• The three offerings collectively target more than $3.5 trillion in market capitalisation against a US IPO market that raised just $45 billion in all of 2025.

• Capital rotation out of existing AI proxy positions into pure-play listings poses a structural headwind for some of the most widely held stocks in institutional portfolios.

The Proxy Decade and Why It Existed

For most of the past four years, artificial intelligence was a private market phenomenon. The companies building frontier models, training large language systems, and competing for the next architectural breakthrough were unavailable to public investors. The leading labs operated behind closed funding rounds, sovereign wealth allocations, and venture capital agreements that most institutional mandates could not access.

Markets found a workaround. Investors who wanted exposure to the AI build-out bought the companies surrounding it. Nvidia (NASDAQ: NVDA) became the default expression of AI infrastructure demand, its GPU revenues functioning as a real-time proxy for aggregate model training activity across the sector. Microsoft (NASDAQ: MSFT) carried an approximate 27% stake in OpenAI, embedding AI optionality into a broadly held technology holding. Alphabet (NASDAQ: GOOGL) served as both an AI developer through its own DeepMind operations and as a strategic backer of Anthropic, giving investors indirect exposure to the two most commercially significant frontier labs simultaneously.

This arrangement was never structurally clean. Owning Nvidia for AI exposure also meant owning its data centre cyclicality, its gaming segment, and its China export risk. Owning Microsoft for OpenAI meant simultaneously holding Teams, Azure, LinkedIn, and a legacy enterprise software business. The AI thesis was always bundled inside larger, more complex companies. Investors accepted this compromise because no better option existed.

The 2026 IPO Cohort Changes the Equation

That constraint is now being removed. SpaceX completed the largest IPO in history on June 12, raising $75 billion before underwriters exercised their overallotment option, and listing on the Nasdaq under the ticker SPCX at a price of $135 per share. The debut placed SpaceX among the most valuable public companies on earth from its first trading session.

Behind it, the pipeline is substantial. Anthropic confidentially filed its S-1 with the SEC on June 1, with OpenAI following exactly one week later on June 8. Goldman Sachs and Morgan Stanley are running both deals, each expected to raise at least $60 billion. Anthropic is targeting an October 2026 Nasdaq listing at a valuation of roughly $965 billion, with investment bankers treating a debut above $1 trillion as the base case. OpenAI, meanwhile, is targeting a valuation of $730 billion to $850 billion for a late 2026 or early 2027 public debut.

The combined scale is without precedent in modern capital markets. The three companies represent more than $3.5 trillion in private-market value. The entire US IPO market raised $45 billion in all of 2025. These three companies alone could demand north of $200 billion from public markets.

The Scarcity Premium and What Happens to It

The defining dynamic of the AI equity trade since 2022 has been scarcity. Because the frontier labs were private, investors paid a premium for anything with credible AI exposure. That scarcity premium is embedded in current valuations across the Magnificent Seven. It reflects not just what those companies are worth on their own fundamentals, but also the additional demand from investors who had no other route into pure-play AI.

Once investors can buy direct exposure to the AI leaders, they may fund those purchases by trimming existing holdings in hyperscalers and other public AI proxies. In that sense, the coming IPO wave may be less a market-top signal than a test of the scarcity premium embedded in today's AI winners.

The rotation dynamic is most acute for stocks whose AI premium is structural rather than fundamental. Microsoft and SoftBank face a more ambiguous outcome as both hold stakes that will be marked-to-market upon listing, and the debut of OpenAI may prompt outflows from investors who have used either stock as an OpenAI proxy. SoftBank, which trades more explicitly as an AI holding vehicle, faces the greater rotation risk of the two.

The Market Absorption Question

Whether public markets can absorb this volume of new issuance without significant disruption is the central structural question now facing institutional portfolio managers.

The bull case rests on the depth of available liquidity. There is an estimated $8 trillion sitting in US money market funds. SpaceX's $75 billion raise represents roughly 1% of that. Demand for the SpaceX offering was reportedly more than three times oversubscribed, suggesting institutional appetite for direct AI and space exposure is genuine and deep.

The modest selling across the Magnificent Seven, crypto, and money market funds should provide ample capital to responsibly allocate to mega-IPOs without exhausting aftermarket buying power.

The bear case is more nuanced. For passive funds, including the index mutual funds and ETFs that underpin millions of 401(k) plans and individual brokerage accounts, index inclusion is not optional. When a stock enters a benchmark, funds tracking that index are effectively required to buy it, and that mechanical demand can move markets, compress liquidity windows, and force portfolio managers to liquidate existing positions. MSCI has formally warned institutional managers to stress-test portfolios against multiple float scenarios ahead of the IPO wave.

The SpaceX Post-IPO Signal

The early trading history of SPCX offers a useful framework for what may follow with Anthropic and OpenAI. The stock peaked at $225.64 intraday on June 16 before falling in three consecutive sessions, trading near $165 as of June 22, down roughly 27% from its peak but still approximately 22% above the $135 IPO price.

At one point during its run-up, SpaceX topped Amazon and Microsoft to become the fourth most valuable public company. Insiders could potentially sell 44% of SpaceX shares by early September, increasing the current float by approximately 900%. That supply dynamic represents a material valuation risk that public market investors must price into any comparable AI listing.

The analytical takeaway is not that the SpaceX IPO failed. It did not. It is that public markets apply a different discipline than private funding rounds. Quarterly reporting, short selling, passive rebalancing, and real-time price discovery create accountability mechanisms that private valuation processes do not. Former Nasdaq chief noted that Anthropic and OpenAI have a more clear and present business model than SpaceX, and that SpaceX has opened the IPO window through which other companies will now fly.

Valuation Frameworks Under Pressure

The S-1 filings for Anthropic and OpenAI will represent the first moment that private-market valuations meet public-market scrutiny at this scale. Anthropic's annualised revenue run-rate crossed $47 billion in May 2026, up from a reported $9 billion target for 2025, and approximately 80% of that revenue comes from enterprise customers. That trajectory is the primary basis for investment bankers projecting a debut above $1 trillion.

OpenAI's numbers carry a different risk profile. The company is generating $2 billion in revenue per month, growing four times faster than Alphabet and Meta did at comparable stages, with enterprise now making up more than 40% of revenue. The company is not yet profitable. A loss-making company entering public markets at nearly $900 billion will face ongoing pressure to demonstrate a credible path to operating leverage within the normal investor time horizon.

Three mega-IPOs hitting the same pool of institutional capital within a short window raises structural questions about whether one or both AI lab listings face valuation compression if investor appetite is even partially satisfied by SpaceX.

What the Structural Shift Means for Portfolio Positioning

The 2026 AI IPO cohort does not render existing AI proxy holdings worthless. Nvidia's revenue remains directly linked to the compute requirements of the same labs now going public. Alphabet's infrastructure relationships with both Anthropic and Google DeepMind provide genuine AI revenue, not merely optionality. Microsoft's Azure platform underpins meaningful portions of OpenAI's commercial deployment.

What changes is the marginal investor logic. Allocators who held these companies specifically to gain AI exposure, and who paid a valuation premium for that access, now face a more direct choice. The proxy trade served a purpose in the absence of alternatives. With pure-play listings arriving, the rationale for holding AI exposure through bundled intermediaries weakens at the margin, and capital allocation frameworks across the technology sector will need to reflect that shift.

The remainder of 2026 will determine how significant that realignment becomes. Anthropic's October listing is the next major data point, functioning as the market's first direct referendum on whether frontier AI model developers can sustain trillion-dollar valuations under full public scrutiny. The answer will carry implications well beyond the three companies currently queued for listing.